Counteracting the enzymatic activity of dipeptidylpeptidase 4 for potential therapeutic advantage, with an emphasis on cord blood transplantation

키워드

참고문헌 (42)

1. Broxmeyer HE, "Cord blood hematopoietic cell transplantation, In Thomas’ Hematopoietic Cell Transplantation. 5th ed" (2013), Wiley-Blackwell
2. Shaheen M, "The humoral regulation of hematopoiesis, In Hematology: Basic Principles and Practice. 5th ed", pp.253~275 (1998), Elsevier Churchill Livingston
3. Shaheen M, "Hematopoietic cytokines and growth factors, In Cord Blood Biology, Transplantation, Banking, and Regulation", pp.35~74 (2011), AABB Press
4. Broxmeyer HE, "Will iPS cells enhance therapeutic applicability of cord blood cells and banking?", Cell Stem Cell, 6, pp.21~24 (2010)
5. Shaheen M, "Principles of cytokine signaling, In Hematology: Basic Principles and Practice. 6th ed", pp.136~146 (2013), Elsevier Saunders
6. Ballen KK, "Umbilical cord blood transplantation: the first 25 years and beyond", Blood, 122, pp.491~498 (2013)
7. Gluckman E, "Hematopoietic reconstitution in a patient with Fanconi’s anemia by means of umbilical-cord blood from an HLA-identical sibling", N Engl J Med, 321, pp.1174~1178 (1989)
8. Wagner JE, "Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and nonmalignant disease", Lancet, 346, pp.214~219 (1995)
9. Broxmeyer HE, "Human umbilical cord blood as a potential source of transplantable hematopoietic stem", progenitor cells, 1989, pp.86, 3828~3832
10. Broxmeyer HE, "Umbilical cord blood hematopoietic stem and repopulating cells in human clinical transplantation", Blood Cells, 17, pp.313~329 (1991)
11. Carow CE, "Mast cell growth factor (c-kit ligand) supports the growth of human multipotential progenitor cells with a high replating potential", Blood, 78, pp.2216~2221 (1991)
12. Broxmeyer HE, "Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults", Proc Natl Acad Sci U S A, 89, pp.4109~4113 (1992)
13. Carow CE, "Human multipotential progenitor cells (CFU-GEMM) have extensive replating capacity for secondary CFU-GEMM: an effect enhanced by cord blood plasma", Blood, 81, pp.942~949 (1993)
14. Lu L, "Enrichment, characterization, and responsiveness of single primitive CD34 human umbilical cord blood hematopoietic progenitors with high proliferative and replating potential", Blood, 81, pp.41~48 (1993)
15. Vormoor J, "Immature human cord blood progenitors engraft and proliferate to high levels in severe combined immunodeficient mice", Blood, 83, pp.2489~2497 (1994)
16. Bock TA, "Improved engraftment of human hematopoietic cells in severe combined immunodef icient (SCID) mice carrying human cytokine transgenes", J Exp Med, 182, pp.2037~2043 (1995)
17. Broxmeyer HE, "High-efficiency recovery of immature haematopoietic progenitor cells with extensive proliferative capacity from human cord blood cryopreserved for 10 years", Clin Exp Immunol, 107(1), pp.45~53 (1997)
18. Broxmeyer HE, "High-efficiency recovery of functional hematopoietic progenitor and stem cells from human cord blood cryopreserved for 15 years", Proc Natl Acad Sci U S A, 100, pp.645~650 (2003)
19. Broxmeyer HE, "Hematopoietic stem", progenitor cells, generation of induced pluripotent stem cells, and isolation of endothelial progenitors from 21- to 23.5-year cryopreserved cord blood, 2011, pp.117, 4773~4777
20. Rocha V, "New approaches for improving engraftment after cord blood transplantation", Biol Blood Marrow Transplant, 16(1), pp.126~132 (2010)
21. Hopsu-Havu VK, "A new dipeptide naphthylamidase hydrolyzing glycyl-prolyl-beta-naphthylamide", Histochemie, 7, pp.197~201 (1966)
22. Martin RA, "Dipeptidyl peptidase IV (DPP-IV) from pig kidney cleaves analogs of bovine growth hormonereleasing factor (bGRF) modified at position 2 with Ser, Thr or Val: extended DPP-IV substrate specificity?", Biochim Biophys Acta, 1164, pp.252~260 (1993)
23. Campbell TB, "CD26 inhibition and hematopoiesis: a novel approach to enhance transplantation", Front Biosci, 13, pp.1795~1805 (2008)
24. Broxmeyer HE, "Dipeptidylpeptidase 4 negatively regulates colony-stimulating factor activity and stress hematopoiesis", Nat Med, 18, pp.1786~1796 (2012)
25. Solau-Gervais E, "Cysteine and serine proteases of synovial tissue in rheumatoid arthritis and osteoarthritis", Scand J Rheumatol, 36, pp.373~377 (2007)
26. Lambeir AM, "prediction of DPP IV", CD26 domain structure from a physicochemical investigation of dipeptidyl peptidase IV (CD26) from human seminal plasma, 1997, pp.1340, 215~226
27. Christopherson KW 2nd, "Cell surface peptidase CD26", dipeptidylpeptidase IV regulates CXCL12, J Immunol, pp.2002, 169[DOI]
28. Christopherson KW 2nd, "Modulation of hematopoietic stem cell homing and engraftment by CD26", Science, 305, pp.1000~1003 (2004)
29. Christopherson KW, "CD26 is essential for normal G-CSF-induced progenitor cell mobilization as determined by CD26-", - mice, 2003, pp.31, 1126~1134
30. Christopherson KW 2nd, "Cell surface peptidase CD26", DPPIV mediates G-CSF mobilization of mouse progenitor cells, 2003, pp.101, 4680~4686
31. Tian C, "Inhibition of CD26 peptidase activity significantly improves engraftment of retrovirally transduced hematopoietic progenitors", Gene Ther, 13, pp.652~658 (2006)
32. Peranteau WH, "CD26 inhibition enhances allogeneic donor-cell homing and engraftment after in utero hematopoietic- cell transplantation", Blood, 108, pp.4268~4274 (2006)
33. Wyss BK, "Enhanced homing and engraftment of fresh but not ex vivo cultured murine marrow cells in submyeloablated hosts following CD26 inhibition by Diprotin A", Exp Hematol, 37, pp.814~823 (2009)
34. Campbell TB, "Inhibition of CD26 in human cord blood CD34+ cells enhances their engraftment of nonobese diabetic", severe combined immunodeficiency mice, 2007, pp.16, 347~354
35. Christopherson KW 2nd, "CD26 inhibition on CD34+ or lineage- human umbilical cord blood donor hematopoietic stem cells", hematopoietic progenitor cells improves long-term engraftment into NOD, Beta2null immunodeficient mice, pp.Stem Cells Dev, 2007[DOI]
36. Kawai T, "Diprotin A infusion into nonobese diabetic", severe combined immunodeficiency mice markedly enhances engraftment of human mobilized CD34+ peripheral blood cells, 2007, pp.16, 361~370
37. Farag SS, "In vivo DPP-4 inhibition to enhance engraftment of singleunit cord blood transplants in adults with hematological malignancies", Stem Cells Dev, 22, pp.1007~1015 (2013)
38. Bergman AJ, "Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers", Clin Ther, 28, pp.55~72 (2006)
39. Rubinstein P, "Outcomes among 562 recipients of placental-blood transplants from unrelated donors", N Engl J Med, 339, pp.1565~1577 (1998)
40. Ou X, "Implications of DPP4 modification of proteins that regulate stem", progenitor and more mature cell types, 2013, pp.122, 161~169
41. O’Leary H, "The role of dipeptidyl peptidase 4 in hematopoiesis and transplantation", Curr Opin Hematol, 20, pp.314~319 (2013)
42. Chua S, "Sitagliptin therapy enhances the number of circulating angiogenic cells and angiogenesis-evaluations in vitro and in the rat critical limb ischemia model", Cytotherapy, 15, pp.1148~1163 (2013)

관련 논문AI추천